BTK-PROTAC

N/A

Report date: 2023/02/20 14:18:43
NME

Base Information

Drug NameBTK-PROTAC
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase BTK degraders
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsAutoimmune DiseasesHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEnhancedBio Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnhancedBio Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A